Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 187
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

    Does Zika virus replicate in neural cells?

    Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

    Developing A New Treatment For Neurodegenerative Diseases

    1 in 3 people over the age of 65 will die with Alzheimer's disease or some other form of dementia. Current...

    Backer Badge Funded